Intrinsic Value of S&P & Nasdaq Contact Us

Cencora, Inc. COR NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$386.89
+20.9%
Analyst Price Target
$408.00
+27.5%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Cencora, Inc. (COR) has shown strong revenue growth over the past 3 years, expanding from $238.6B to $321.3B (average +10.4%/yr). Net income reached $1.6B, reflecting earnings decline at -2.6%/yr on average. The net profit margin is 0.5%, which is thin. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 3.2% (low), with a -0.3pp trend over the period. With a $62B market cap and MOAT composite score of 49/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (48/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 32-year history, the company was profitable in 30 of 32 years — an excellent long-term track record
  • INCOME (30/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (49/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

53/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
→ IV page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $7.96
Proven by this page
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
Score: 49/100
GM 3.2% (-0.3pp)
Proven by this page
~
GROWTH
48/100
Rev +10.4%/yr
NI -2.6%/yr
Proven by this page
INCOME
30/100
Margin 0.5%
$321.3B
Proven by this page
Cencora, Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $325.78B$321.33B$293.96B$262.17B$238.59B
Gross Profit $11.13B$10.14B$9.91B$8.96B$8.33B
Gross Margin 3.4%3.2%3.4%3.4%3.5%
Operating Income $3.89B$3.65B$2.18B$2.34B$2.37B
Net Income $1.63B$1.55B$1.51B$1.75B$1.7B
Net Margin 0.5%0.5%0.5%0.7%0.7%
EPS (Diluted) $8.32$7.96$7.53$8.53$8.04
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message